In addition, our study focused on young and aging AD mice and has shown that chronic hypoperfusion may accelerate AD neuropathology in a latent manner over an extended period of time via the enhancement of Tau phosphorylation23, 39, 40, 41. This evidence concerns the gene MAPT and Alzheimer disease.